The Anticancer Effects of Resveratrol: Modulation of Transcription Factors

REFERENCES

• Surh , Y-J . 2003 . Cancer chemoprevention with dietary phytochemicals . Nat Rev Cancer , 3 : 768 – 780 .
   PubMed Web of Science ®Google Scholar
• Baur , J A and Sinclair , D A . 2006 . Therapeutic potential of resveratrol: the in vivo evidence . Nat Rev Drug Discov , 5 : 493 – 506 .
   PubMed Web of Science ®Google Scholar
• Jang , M , Cai , L , Udeani , G O , Slowing , K V Thomas , C F . 1997 . Cancer chemopreventive activity of resveratrol, a natural product derived from grapes . Science , 275 : 218 – 220 .
   PubMed Web of Science ®Google Scholar
• Kundu , J K and Surh , Y-J . 2008 . Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives . Cancer Lett , 269 : 243 – 261 .
   PubMed Web of Science ®Google Scholar
• Bishayee , A . 2009 . Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials . Cancer Prev Res , 2 : 409 – 418 .
   PubMed Web of Science ®Google Scholar
• Bhardwaj , A , Sethi , G , Vadhan-Raj , S , Bueso-Ramos , C Takada , Y . 2007 . Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells . Blood , 109 : 2293 – 2302 .
   PubMed Web of Science ®Google Scholar
• Gatouillat , G , Balasse , E , Joseph-Pietras , D , Morjani , H and Madoulet , C . 2010 . Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma . J Cell Biochem , 110 : 893 – 902 .
   PubMed Web of Science ®Google Scholar
• Harikumar , K B , Kunnumakkara , A B , Sethi , G , Diagaradjane , P Anand , P . 2010 . Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer . Int J Cancer , 127 : 257 – 268 .
   PubMed Web of Science ®Google Scholar
• Shankar , S , Chen , Q , Siddiqui , I , Sarva , K and Srivastava , R . 2007 . Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4′, 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential . J Mol Signal , 2 : 7
   PubMedGoogle Scholar
• Androutsopoulos , V , Tsatsakis , A and Spandidos , D . 2009 . Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention . BMC Cancer , 9 : 187
   PubMed Web of Science ®Google Scholar
• Lee , J-E and Safe , S . 2001 . Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells . Biochem Pharmacol , 62 : 1113 – 1124 .
   PubMed Web of Science ®Google Scholar
• Dietrich , C and Kaina , B . 2010 . The aryl hydrocarbon receptor (AhR) in the regulation of cell–cell contact and tumor growth . Carcinogenesis , 31 : 1319 – 1328 .
   PubMed Web of Science ®Google Scholar
• Beedanagari , S R , Bebenek , I , Bui , P and Hankinson , O . 2009 . Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes . Toxicol Sci , 110 : 61 – 67 .
   PubMed Web of Science ®Google Scholar
• Perdew , G H , Hollingshead , B D , DiNatale , B C , Morales , J L Labrecque , M P . 2010 . Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity . J Pharmacol Exp Ther , 335 : 273 – 283 .
   PubMed Web of Science ®Google Scholar
• MacPherson , L and Matthews , J . 2010 . Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells . Cancer Lett , 299 : 119 – 129 .
   PubMed Web of Science ®Google Scholar
• Peng , T-L , Chen , J , Mao , W , Song , X and Chen , M-H . 2009 . Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9 . BMC Cell Biol , 10 : 27
   PubMed Web of Science ®Google Scholar
• Kensler , T W and Wakabayashi , N . 2010 . Nrf2: friend or foe for chemoprevention? . Carcinogenesis , 31 : 90 – 99 .
   PubMed Web of Science ®Google Scholar
• Bishayee , A , Barnes , K F , Bhatia , D , Darvesh , A S and Carroll , R T . 2010 . Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis . Cancer Prev Res , 3 : 753 – 763 .
   PubMed Web of Science ®Google Scholar
• Lu , F , Zahid , M , Wang , C , Saeed , M Cavalieri , E L . 2008 . Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells . Cancer Prev Res , 1 : 135 – 145 .
   PubMed Web of Science ®Google Scholar
• Zahid , M , Gaikwad , N W , Ali , M F , Lu , F Saeed , M . 2008 . Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol . Free Radic Biol Med , 45 : 136 – 145 .
   PubMed Web of Science ®Google Scholar
• Zhang , H , Shih , A , Rinna , A and Forman , H J . 2011 . Exacerbation of tobacco smoke mediated apoptosis by resveratrol: an unexpected consequence of its antioxidant action . Int J Biochem Cell Biol , 43 : 1059 – 1064 .
   PubMed Web of Science ®Google Scholar
• Kode , A , Rajendrasozhan , S , Caito , S , Yang , S-R Megson , I L . 2008 . Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells . Am J Physiol Lung Cell Mol Physiol , 294 : L478 – L488 .
   PubMed Web of Science ®Google Scholar
• Rubiolo , J A , Mithieux , G and Vega , F V . 2008 . Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes . Eur J Pharmacol , 591 : 66 – 72 .
   PubMed Web of Science ®Google Scholar
• Hsieh , T-c , Lu , X , Wang , Z and Wu , J M . 2006 . Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element are and is accompanied by nuclear translocation of transcription factor Nrf2 . Med Chem , 2 : 275 – 285 .
   PubMedGoogle Scholar
• Kawai , Y , Garduño , L , Theodore , M , Yang , J and Arinze , I J . 2011 . Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization . J Biol Chem , 286 : 7629 – 7640 .
   PubMed Web of Science ®Google Scholar
• Farnebo , M , Bykov , V JN and Wiman , K G . 2010 . The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer . Biochem Biophys Res Commun , 396 : 85 – 89 .
   PubMed Web of Science ®Google Scholar
• Fan , E , Jiang , S , Zhang , L and Bai , Y . 2008 . Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent . Int J Vitam Nutr Res , 78 : 3 – 8 .
   PubMed Web of Science ®Google Scholar
• Heiss , E H , Schilder , Y DC and Dirsch , V M . 2007 . Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells . J Biol Chem , 282 : 26759 – 26766 .
   PubMed Web of Science ®Google Scholar
• Madan , E , Prasad , S , Roy , P , George , J and Shukla , Y . 2008 . Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells . Biochem Biophys Res Commun , 377 : 1232 – 1237 .
   PubMed Web of Science ®Google Scholar
• Singh , N , Nigam , M , Ranjan , V , Sharma , R Balapure , A K . 2009 . Caspase mediated enhanced apoptotic action of cyclophosphamide-and resveratrol-treated MCF-7 cells . J Pharmacol Sci , 109 : 472 – 485 .
   Web of Science ®Google Scholar
• Bishayee , A and Dhir , N . 2009 . Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis . Chem Biol Interact , 179 : 131 – 144 .
   PubMed Web of Science ®Google Scholar
• Shankar , S , Siddiqui , I and Srivastava , R . 2007 . Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells . Mol Cell Biochem , 304 : 273 – 285 .
   PubMed Web of Science ®Google Scholar
• Jiang , H , Zhang , L , Kuo , J , Kuo , K Gautam , S C . 2005 . Resveratrol-induced apoptotic death in human U251 glioma cells . Mol Cancer Ther , 4 : 554 – 561 .
   PubMed Web of Science ®Google Scholar
• Jazirehi , A R and Bonavida , B . 2004 . Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis . Mol Cancer Ther , 3 : 71 – 84 .
   PubMed Web of Science ®Google Scholar
• Tyagi , A , Singh , R P , Agarwal , C , Siriwardana , S Sclafani , R A . 2005 . Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR–Chk1/2–Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells . Carcinogenesis , 26 : 1978 – 1987 .
   PubMed Web of Science ®Google Scholar
• Kai , L , Samuel , S K and Levenson , A S . 2010 . Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex . Int J Cancer , 126 : 1538 – 1548 .
   PubMed Web of Science ®Google Scholar
• Baek , S J , Wilson , L C and Eling , T E . 2002 . Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 . Carcinogenesis , 23 : 425 – 432 .
   PubMed Web of Science ®Google Scholar
• Fu , Z and Tindall , D J . 2008 . FOXOs, cancer and regulation of apoptosis . Oncogene , 27 : 2312 – 2319 .
   PubMed Web of Science ®Google Scholar
• Zhang , X , Tang , N , Hadden , T J and Rishi , A K . in press . Akt, FoxO and regulation of apoptosis . Biochim Biophys Acta ,
   Web of Science ®Google Scholar
• Brunet , A , Sweeney , L B , Sturgill , J F , Chua , K F Greer , P L . 2004 . Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase . Science , 303 : 2011 – 2015 .
   PubMed Web of Science ®Google Scholar
• van der Horst , A , Tertoolen , L GJ , de Vries-Smits , L MM , Frye , R A Medema , R H . 2004 . FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1 . J Biol Chem , 279 : 28873 – 28879 .
   PubMed Web of Science ®Google Scholar
• Yang , Y , Hou , H , Haller , E M , Nicosia , S V and Bai , W . 2005 . Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation . EMBO J , 24 : 1021 – 1032 .
   PubMed Web of Science ®Google Scholar
• Ford , J , Jiang , M and Milner , J . 2005 . Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival . Cancer Res , 65 : 10457 – 10463 .
   PubMed Web of Science ®Google Scholar
• Chen , Q , Ganapathy , S , Singh , K P , Shankar , S and Srivastava , R K . 2010 . Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells . PLoS ONE , 5 : e15288
   PubMed Web of Science ®Google Scholar
• Ganapathy , S , Chen , Q , Singh , K P , Shankar , S and Srivastava , R K . 2010 . Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor . PLoS ONE , 5 : e15627
   PubMed Web of Science ®Google Scholar
• Srivastava , R , Unterman , T and Shankar , S . 2010 . FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol . Mol Cell Biochem , 337 : 201 – 212 .
   PubMed Web of Science ®Google Scholar
• Ni , Y G , Wang , N , Cao , D J , Sachan , N Morris , D J . 2007 . FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases . Proc Natl Acad Sci , 104 : 20517 – 20522 .
   PubMed Web of Science ®Google Scholar
• Wu , Y and Zhou , B . 2009 . Inflammation: a driving force speed cancer metastasis . Cell Cycle , 8 : 3267 – 3273 .
   PubMed Web of Science ®Google Scholar
• Muriel , P . 2009 . NF-κB in liver diseases: a target for drug therapy . J Appl Toxicol , 29 : 91 – 100 .
   PubMed Web of Science ®Google Scholar
• Roy , P , Kalra , N , Nigam , N , George , J Ray , R S . 2009 . Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-κB pathway in human epidermoid carcinoma A431 cells . Biochem Biophys Res Commun , 384 : 215 – 220 .
   PubMed Web of Science ®Google Scholar
• Benitez , D A , Hermoso , M A , Pozo-Guisado , E , Fernández-Salguero , P M and Castellón , E A . 2009 . Regulation of cell survival by resveratrol involves inhibition of NFκB-regulated gene expression in prostate cancer cells . Prostate , 69 : 1045 – 1054 .
   PubMed Web of Science ®Google Scholar
• Estrov , Z , Shishodia , S , Faderl , S , Harris , D Van , Q . 2003 . Resveratrol blocks interleukin-1{beta}-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells . Blood , 102 : 987 – 995 .
   PubMed Web of Science ®Google Scholar
• Yu , H , Pan , C , Zhao , S , Wang , Z Zhang , H . 2008 . Resveratrol inhibits tumor necrosis factor-α-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells . Biomed Pharmacother , 62 : 366 – 372 .
   PubMed Web of Science ®Google Scholar
• Liu , P-L , Tsai , J-R , Charles , A L , Hwang , J-J Chou , S-H . 2010 . Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases . Mol Nutr Food Res , 54 : S196 – S204 .
   PubMed Web of Science ®Google Scholar
• Sun , C , Hu , Y , Liu , X , Wu , T Wang , Y . 2006 . Resveratrol downregulates the constitutional activation of nuclear factor-κB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis . Cancer Genet Cytogenet , 165 : 9 – 19 .
   PubMed Web of Science ®Google Scholar
• Bishayee , A , Waghray , A , Barnes , K , Mbimba , T Bhatia , D . 2010 . Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis . Pharm Res , 27 : 1080 – 1091 .
   PubMed Web of Science ®Google Scholar
• Park , J , Kim , K , Kim , M , Chang , H Baek , M . 2009 . Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression . Anticancer Res , 29 : 355 – 362 .
   PubMed Web of Science ®Google Scholar
• Whitlock , N C , Bahn , J H , Lee , S-H , Eling , T E and Baek , S J . 2011 . Resveratrol-induced apoptosis is mediated by early growth response-1, krüppel-like factor 4, and activating transcription factor 3 . Cancer Prev Res , 4 : 116 – 127 .
   PubMed Web of Science ®Google Scholar
• Lu , D , Chen , J and Hai , T . 2007 . The regulation of ATF3 gene expression by mitogen-activated protein kinases . Biochem J , 401 : 559 – 567 .
   PubMed Web of Science ®Google Scholar
• Yan , C and Boyd , D D . 2006 . ATF3 regulates the stability of p53: a link to cancer . Cell Cycle , 5 : 926 – 929 .
   PubMed Web of Science ®Google Scholar
• Fan , F , Jin , S , Amundson , S A , Tong , T Fan , W . 2002 . ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cell growth . Oncogene , 21 : 7488 – 7495 .
   PubMed Web of Science ®Google Scholar
• Huang , X , Li , X and Guo , B . 2008 . KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3 . J Biol Chem , 283 : 29795 – 29801 .
   PubMed Web of Science ®Google Scholar
• Lu , D , Wolfgang , C D and Hai , T . 2006 . Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis . J Biol Chem , 281 : 10473 – 10481 .
   PubMed Web of Science ®Google Scholar
• Yamaguchi , K , Lee , S-H , Kim , J-S , Wimalasena , J Kitajima , S . 2006 . Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase–independent pathway . Cancer Res , 66 : 2376 – 2384 .
   PubMed Web of Science ®Google Scholar
• Turchi , L , Aberdam , E , Mazure , N , Pouyssegur , J Deckert , M . 2008 . Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway . Cell Death Diff , 15 : 1472 – 1480 .
   PubMed Web of Science ®Google Scholar
• Bottone , F G , Moon , Y , Kim , J S , Alston-Mills , B Ishibashi , M . 2005 . The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3) . Mol Cancer Ther , 4 : 693 – 703 .
   PubMed Web of Science ®Google Scholar
• Stearns , M E , Kim , G , Garcia , F and Wang , M . 2004 . Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 cells . Mol Cancer Res , 2 : 403 – 416 .
   PubMed Web of Science ®Google Scholar
• Yan , C , Wang , H and Boyd , D D . 2002 . ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter . J Biol Chem , 277 : 10804 – 10812 .
   PubMed Web of Science ®Google Scholar
• Lee , S-H , Kim , J-S , Yamaguchi , K , Eling , T E and Baek , S J . 2005 . Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner . Biochem Biophys Res Commun , 328 : 63 – 69 .
   PubMed Web of Science ®Google Scholar
• Yan , C , Jamaluddin , M S , Aggarwal , B , Myers , J and Boyd , D D . 2005 . Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin . Mol Cancer Ther , 4 : 233 – 241 .
   PubMed Web of Science ®Google Scholar
• Mashima , T , Udagawa , S and Tsuruo , T . 2001 . Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis . J Cell Physiol , 188 : 352 – 358 .
   PubMed Web of Science ®Google Scholar
• Wang , Q , Mora-Jensen , H , Weniger , M A , Perez-Galan , P Wolford , C . 2009 . ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells . Proc Natl Acad Sci , 106 : 2200 – 2205 .
   PubMed Web of Science ®Google Scholar
• Thiel , G and Cibelli , G . 2002 . Regulation of life and death by the zinc finger transcription factor Egr-1 . J Cell Physiol , 193 : 287 – 292 .
   PubMed Web of Science ®Google Scholar
• Zhang , W , Geiman , D E , Shields , J M , Dang , D T Mahatan , C S . 2000 . The gut-enriched Krüppel-like Factor (Krüppel-like Factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter . J Biol Chem , 275 : 18391 – 18398 .
   PubMed Web of Science ®Google Scholar
• Yan , S-F , Fujita , T , Lu , J , Okada , K Shan Zou , Y . 2000 . Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress . Nat Med , 6 : 1355 – 1361 .
   PubMed Web of Science ®Google Scholar
• Zhou , Q , Hong , Y , Zhan , Q , Shen , Y and Liu , Z . 2009 . Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage . Cancer Res , 69 : 8284 – 8292 .
   PubMed Web of Science ®Google Scholar
• Liu , C , Rangnekar , V , Adamson , E and Mercola , D . 1998 . Suppression of growth and transformation and induction of apoptosis by EGR-1 . Cancer Gene Ther , 5 : 3 – 28 .
   PubMed Web of Science ®Google Scholar
• Yoon , H S , Chen , X and Yang , V W . 2003 . Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage . J Biol Chem , 278 : 2101 – 2105 .
   PubMed Web of Science ®Google Scholar
• Baron , V , De Gregorio , G , Krones-Herzig , A , Virolle , T Calogero , A . 2003 . Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo . Oncogene , 22 : 4194 – 4204 .
   PubMed Web of Science ®Google Scholar
• Chen , Y-J , Wu , C-Y , Chang , C-C , Ma , C-J Li , M-C . 2008 . Nuclear Kruppel-like factor 4 expression is associated with human skim squamous cell carcinoma progression and metastasis . Cancer Biol Ther , 7 : 777 – 782 .
   PubMed Web of Science ®Google Scholar
• Pandya , A Y , Talley , L I , Frost , A R , Fitzgerald , T J Trivedi , V . 2004 . Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer . Clin Cancer Res , 10 : 2709 – 2719 .
   PubMed Web of Science ®Google Scholar
• Lee , S-H , Bahn , J H , Choi , C K , Whitlock , N C English , A E . 2008 . ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells . Mol Cancer Ther , 7 : 3739 – 3750 .
   PubMed Web of Science ®Google Scholar
• Choi , B H , Kim , C G , Bae , Y-S , Lim , Y Lee , Y H . 2008 . p21Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression . Cancer Res , 68 : 1369 – 1377 .
   PubMed Web of Science ®Google Scholar
• Park , S E , Lee , S W , Hossain , M A , Kim , M Y Kim , M-N . 2008 . A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells . Cancer Lett , 270 : 77 – 86 .
   PubMed Web of Science ®Google Scholar
• Zagurovskaya , M , Shareef , M M , Das , A , Reeves , A Gupta , S . 2009 . EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells . Oncogene , 28 : 1121 – 1131 .
   PubMed Web of Science ®Google Scholar
• Ghaleb , A M , McConnell , B B , Nandan , M O , Katz , J P Kaestner , K H . 2007 . Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis . Cancer Res , 67 : 7147 – 7154 .
   PubMed Web of Science ®Google Scholar
• Hu , W , Hofstetter , W L , Li , H , Zhou , Y He , Y . 2009 . Putative tumor-suppressive function of Krüppel-like factor 4 in primary lung carcinoma . Clin Cancer Res , 15 : 5688 – 5695 .
   PubMed Web of Science ®Google Scholar
• Wei , D , Kanai , M , Jia , Z , Le , X and Xie , K . 2008 . Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells . Cancer Res , 68 : 4631 – 4639 .
   PubMed Web of Science ®Google Scholar